American Biotech Firm Axiom Biosciences to List in Hong Kong Before Wall Street

This Data Is Locked!

This area is available only to Subscribers.

Based in San Diego, Axiom Biosciences is set to seek a primary listing in Hong Kong in 2027, followed by a secondary U.S. listing in... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?